» Articles » PMID: 37986139

Lipid Dysmetabolism in Ceruloplasmin-deficient Mice Revealed Both in Vivo and Ex Vivo by MRI, MRS and NMR Analyses

Overview
Journal FEBS Open Bio
Specialty Biology
Date 2023 Nov 21
PMID 37986139
Authors
Affiliations
Soon will be listed here.
Abstract

Ceruloplasmin (Cp) is a ferroxidase that plays a role in cellular iron homeostasis and is mainly expressed in the liver and secreted into the blood. Cp is also produced by adipose tissue, which releases it as an adipokine. Although a dysfunctional interaction of iron with the metabolism of lipids has been associated with several metabolic diseases, the role of Cp in adipose tissue metabolism and in the interplay between hepatocytes and adipocytes has been poorly investigated. We previously found that Cp-deficient (CpKO) mice become overweight and demonstrate adipose tissue accumulation together with liver steatosis during aging, suggestive of lipid dysmetabolism. In the present study, we investigated the lipid alterations which occur during aging in adipose tissue and liver of CpKO and wild-type mice both in vivo and ex vivo. During aging of CpKO mice, we observed adipose tissue accumulation and liver lipid deposition, both of which are associated with macrophage infiltration. Liver lipid deposition was characterized by accumulation of triglycerides, fatty acids and ω-3 fatty acids, as well as by a switch from unsaturated to saturated fatty acids, which is characteristic of lipid storage. Liver steatosis was preceded by iron deposition and macrophage infiltration, and this was observed to be already occurring in younger CpKO mice. The accumulation of ω-3 fatty acids, which can only be acquired through diet, was associated with body weight increase in CpKO mice despite food intake being equal to that of wild-type mice, thus underlining the alterations in lipid metabolism/catabolism in Cp-deficient animals.

Citing Articles

Ceruloplasmin administration in the preclinical mouse model of aceruloplasminemia reveals a sex-related variation in biodistribution.

Belloli S, Monterisi C, Rainone P, Coliva A, Zanardi A, Conti A Commun Biol. 2025; 8(1):264.

PMID: 39972187 PMC: 11839944. DOI: 10.1038/s42003-025-07714-8.


Murine gut microbial interactions exert antihyperglycemic effects.

Guo L, Xu L, Nie Y, Liu L, Liu Z, Yang Y ISME J. 2025; 19(1).

PMID: 39961020 PMC: 11896791. DOI: 10.1093/ismejo/wraf028.

References
1.
Spinelli R, Parrillo L, Longo M, Florese P, Desiderio A, Zatterale F . Molecular basis of ageing in chronic metabolic diseases. J Endocrinol Invest. 2020; 43(10):1373-1389. PMC: 7481162. DOI: 10.1007/s40618-020-01255-z. View

2.
Wang Q, Zhou D, Wang M, Zhu M, Chen P, Li H . A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population. Front Med (Lausanne). 2022; 9:900794. PMC: 9252518. DOI: 10.3389/fmed.2022.900794. View

3.
Provencher S . Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 2001; 14(4):260-4. DOI: 10.1002/nbm.698. View

4.
Ilyechova E, Tsymbalenko N, Puchkova L . The role of subcutaneous adipose tissue in supporting the copper balance in rats with a chronic deficiency in holo-ceruloplasmin. PLoS One. 2017; 12(4):e0175214. PMC: 5402356. DOI: 10.1371/journal.pone.0175214. View

5.
Vroegindeweij L, van der Beek E, Boon A, Hoogendoorn M, Kievit J, Wilson J . Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series. Diabet Med. 2015; 32(8):993-1000. DOI: 10.1111/dme.12712. View